Apellis Pharmaceuticals, Inc. APLS
APLS
Apellis Pharmaceuticals, Inc. CPRX
Catalyst Pharmaceuticals, Inc. KNSA
Kiniksa Pharmaceuticals, Ltd. MLYS
Mineralys Therapeutics, Inc. BEAM
Beam Therapeutics Inc. CDTX
Cidara Therapeutics, Inc. ADPT
Adaptive Biotechnologies Corporation SRRK
Scholar Rock Holding Corporation IDYA
IDEAYA Biosciences, Inc. AGIO
Agios Pharmaceuticals, Inc.
Apellis Pharmaceuticals, Inc. CPRX
Catalyst Pharmaceuticals, Inc. KNSA
Kiniksa Pharmaceuticals, Ltd. MLYS
Mineralys Therapeutics, Inc. BEAM
Beam Therapeutics Inc. CDTX
Cidara Therapeutics, Inc. ADPT
Adaptive Biotechnologies Corporation SRRK
Scholar Rock Holding Corporation IDYA
IDEAYA Biosciences, Inc. AGIO
Agios Pharmaceuticals, Inc.
Performance
| Periode | APLS | CPRX | KNSA | MLYS | BEAM | CDTX | ADPT | SRRK | IDYA | AGIO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 33.99 % | 0.36 % | 47.07 % | 157.61 % | 60.40 % | 865.98 % | 49.61 % | 44.39 % | 53.47 % | -20.47 % |
| YTD | -23.91 % | 9.74 % | 108.73 % | 201.14 % | 10.79 % | 708.17 % | 149.43 % | 6.10 % | 35.29 % | -14.32 % |
| 1Y | -23.98 % | 10.45 % | 106.04 % | 210.00 % | -2.02 % | 864.29 % | 145.08 % | 11.61 % | 35.13 % | -30.00 % |
| 3Y | -52.68 % | 32.67 % | 162.59 % | 100.05 % | -40.17 % | 1 946.66 % | 76.66 % | 456.47 % | 102.74 % | -12.98 % |
| 5Y | -51.53 % | 516.58 % | 113.71 % | 100.05 % | -67.39 % | 438.12 % | -73.00 % | -2.26 % | 144.54 % | -20.12 % |
| 10Y | 79.83 % | 883.96 % | 113.76 % | 100.05 % | 45.95 % | -28.13 % | -61.69 % | 202.29 % | 204.20 % | -43.90 % |
| From the beginning | 79.83 % | 287.13 % | 113.76 % | 100.05 % | 45.95 % | -31.05 % | -61.69 % | 202.29 % | 204.20 % | -12.79 % |